KLI

검색

Ulsan Univ. Repository

Browsing by 저자 : Jae Lyun Lee

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

가 나 다 라 마 바 사 아 자 차 카 타 파 하

또는 첫 단어:

정렬 기준:
정렬:
결과 수
저자 수

전체 결과 20건 중 1-20 번을 표시중입니다.

1 Article Analysis of Anti-Angiogenesis-Related Adverse Events Associated with Vascular Endothelial Growth Factor Receptor-Tyrosine Kinase Inhibitors (VEGFR-TKIs) in Patients with Metastatic Renal Cell Carcinoma Nuri Lee ; Jae Lyun Lee ; Ju-Yeun Lee 2023
2 Article Assessing the Safety and Efficacy of Two Starting Doses of Lenvatinib Plus Everolimus in Patients with Renal Cell Carcinoma: A Randomized Phase 2 Trial Sumanta K Pal ; Javier Puente ; Daniel Y C Heng ; et al 2022
3 Article Atezolizumab plus Magrolimab, Niraparib, or Tocilizumab versus Atezolizumab Monotherapy in Platinum-Refractory Metastatic Urothelial Carcinoma: A Phase Ib/II Open-Label, Multicenter, Randomized Umbrella Study (MORPHEUS Urothelial Carcinoma) Alexandra Drakaki ; Thomas Powles ; Aristotelis Bamias ; et al 2023
4 Article Change of treatment modality and outcomes of adrenocortical carcinoma: a retrospective review of single tertiary center experience over 24 years Cheong-Sil Rah ; Jae Won Cho ; Won Woong Kim ; et al 2022
5 Article Clinical course of patients with renal cell carcinoma or urothelial carcinoma who had stable disease as an initial response to a PD-1 or PD-L1 inhibitor Inhwan Hwang ; Inkeun Park ; Shin-Kyo Yoon ; et al 2022
6 Article Clinical implications of the tumor microenvironment using multiplexed immunohistochemistry in patients with advanced or metastatic renal cell carcinoma treated with nivolumab plus ipilimumab Jwa Hoon Kim ; Gi Hwan Kim ; Yeon-Mi Ryu ; et al 2022
7 Article Effectiveness of Adding Docetaxel to Androgen Deprivation Therapy for Metastatic Hormone-Sensitive Prostate Cancer in Korean Real-World Practice Kwonoh Park ; Jin Young Kim ; Inkeun Park ; et al 2023
8 Article Efficacy and safety of lenvatinib plus pembrolizumab vs sunitinib in the East Asian subset of patients with advanced renal cell carcinoma from the CLEAR trial Sun Young Rha ; Toni K Choueiri ; Vsevolod B Matveev ; et al 2023
9 Article Enfortumab vedotin-related pneumonitis is more common than expected and could lead to acute respiratory failure Shinkyo Yoon ; Sang Joon Shin ; Ho Cheol Kim ; et al 2022
10 Article Glutathione dynamics is a potential predictive and therapeutic trait for neoadjuvant chemotherapy response in bladder cancer YongHwan Kim ; Hyein Ju ; Seung-Yeon Yoo ; et al 2023
11 Article Impact of MET status on treatment outcomes in papillary renal cell carcinoma: A pooled analysis of historical data Laurence Albiges ; Daniel Y C Heng ; Jae Lyun Lee ; et al 2022
12 Article Integrative analysis of risk factors for immune-related adverse events of checkpoint blockade therapy in cancer Changhwan Sung ; Jinhyeon An ; Soohyeon Lee ; et al 2023
13 Article Pembrolizumab plus lenvatinib as first-line therapy for advanced non-clear-cell renal cell carcinoma (KEYNOTE-B61): a single-arm, multicentre, phase 2 trial Laurence Albiges ; Howard Gurney ; Vagif Atduev ; et al 2023
14 Article Pembrolizumab Plus Olaparib for Patients With Previously Treated and Biomarker-Unselected Metastatic Castration-Resistant Prostate Cancer: The Randomized, Open-Label, Phase III KEYLYNK-010 Trial Emmanuel S Antonarakis ; Se Hoon Park ; Jeffrey C Goh ; et al 2023
15 Article Pembrolizumab versus placebo as post-nephrectomy adjuvant therapy for clear cell renal cell carcinoma (KEYNOTE-564): 30-month follow-up analysis of a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial Thomas Powles ; Piotr Tomczak ; Se Hoon Park ; et al 2022
16 Article Primary results of STRONG: An open-label, multicenter, phase 3b study of fixed-dose durvalumab monotherapy in previously treated patients with urinary tract carcinoma Guru P Sonpavde ; Cora N Sternberg ; Yohann Loriot ; et al 2022
17 Article Prognostic model in patients with metastatic urothelial carcinoma receiving immune checkpoint inhibitors after platinum failure Joo-Hwan Park ; Inkeun Park ; In-Ho Kim ; et al 2022
18 Article Real-World Study Evaluating Safety and Effectiveness of Axitinib in Korean Patients with Renal Cell Carcinoma after Failure of One Prior Systemic Therapy Sang Joon Shin ; Jae Lyun Lee ; Tae Gyun Kwon ; et al 2023
19 Article Safety and efficacy of immune checkpoint inhibitors in advanced penile cancer: report from the Global Society of Rare Genitourinary Tumors Talal El Zarif ; Amin H Nassar ; Gregory R Pond ; et al 2023
20 Article The Prognosis and the Role of Adjuvant Chemotherapy for Node-Positive Bladder Cancer Treated with Neoadjuvant Chemotherapy Followed by Surgery Hyehyun Jeong ; Kye Jin Park ; Yongjune Lee ; et al 2022

OAK Ulsan Univ. Repository는 국립중앙도서관 OAK Repository 보급사업으로 구축되었습니다.